QualityStocks News Alert
  The QualityStocks Daily Newsletter for Friday January 16th, 2009 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters


Invest Source (CLSC)


Hot Otc.com (XDSL)


Small Cap Voice (WYDI)

The QualityStocks Daily

HST Global Inc. (HSTC)
Tower Semiconductor Ltd. (TSEM)
MIV Therapeutics Inc. (MIVI)
OpenCell BioMed Inc. (OCBM)

Curis Inc. (CRIS)
Interoil Corp. (IOC)
NACEL Energy Corp. (NCEN)
Sunrise Solar Corporation (SSLR)


HST Global Inc. (HSTC)

Today we are highlighting HST Global Inc. (HSTC) here at the QualityStocks Daily Newsletter.

HST Global Inc. is a development-stage biotechnology company. They acquire and develop innovative products for the treatment of cancer and other life threatening illnesses. The Company lists on the OTCBB and has their corporate headquarters in Hampton , Virginia . Their focus is on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer. They then develop those drug candidates for commercial use. HST Global Inc. is also developing a network of Wellness Centers worldwide.

HST is one of a small number of companies working to create relationships and partnerships for the development of prescription drugs from natural sources. The Company has a holistic perspective and believes that the synergy amongst the parts of a plant or substances from other natural sources have significant value. They believe that plant co-factors, instead of a single chemical entity, will increase the safety and efficacy of the medicines they make.

The Company has focused their efforts on Salicinium, which is their clinical stage drug candidate. They have the rights to a pre-clinical outcome-based study using the homeopathic remedy trade named "salicinium". This is a natural plant-derived substance, which is both oral and a parenteral active inhibitor of certain fermenting enzyme dynamics in cancer cells. Clinical studies demonstrate that salicinium alters malignant cell fermentation dynamics, blocks cell division, and causes fermenting cancer cells to lose their ability to withstand innate immune reactions.

HST Global recently announced plans for the first quarter of fiscal 2009. They are launching their wholly owned division dedicated to opening their own brand of Cancer Treatment Centers. This strategy will enable the Company to address the challenges individuals face in the treatment of cancer in the later stages. They project the annual estimated revenue from each individual clinic to be between 8 to 10 million dollars per year.

Ronald Howell, President, and CEO of HST Global, Inc. stated, "There is a growing population of individuals experiencing the lack of available alternatives in treating late stage cancer. We have been working with a number of highly visible Physicians that are and have developed successful protocols that are meeting with success in the treatment of this population. As such, we will begin opening a privately branded chain of Cancer Treatment Centers strategically positioned around the world through a new wholly owned subsidiary."

HST Global Inc. announced in December the appointment of Dr. Kyl Smith to their Scientific Board. He is a noted researcher, inventor, lecturer, author, and scientist. He is well known as the inventor of Focus Factor®, the number-one selling brain support product in North America for the last seven years.

Today, HST Global Inc. (HSTC) closed at $2.12 down $0.38 or 15.20 percent. Volume was 4,800 for a 3-month average volume of 1,354.69.

Tower Semiconductor Ltd. (TSEM)

Today, Momentum Traders reported on Tower Semiconductor Ltd. (TSEM), Stock Stars did this month, Knobias did previously, and we are highlighting the Company here at the QualityStocks Daily Newsletter.

Headquartered in Migdal Haemek, Israel, Tower Semiconductor Ltd. is a pure-play independent specialty wafer foundry. They manufacture integrated circuits (ICs) with geometries ranging from 1.0 to 0.13 micron. Founded in 1993, they also provide complementary technical services and design support. The Company trades on the NASDAQ Global Market.

Tower Semiconductor Ltd. serves customers in consumer electronics, personal computer and office equipment, communications, automotive and airborne, industrial, professional photography, and medical products markets. Their corporate mission is to provide their clientele with quality, flexible, excellent IC design and manufacturing services.

The Company also offers advanced mixed-signal and RF-CMOS, Power Management, CMOS image-sensor, and non-volatile memory technologies. Through their wholly owned subsidiary, Jazz Semiconductor, Tower offers RF CMOS, Analog CMOS, Silicon and SiGe BiCMOS, SiGe C-BiCMOS, Power CMOS, and High Voltage CMOS. Tower has two manufacturing facilities in Israel . Their Fab 1 has process technologies from 1.0 to 0.35 micron and can produce up to 16,000 150mm wafers per month.

Their Fab2 features 0.18-micron and below standard and specialized process technologies. Tower expects Fab2 to offer full production capacity of 40,000 200mm wafers per month when equipped fully. Tower also has access to Jazz Semiconductor's facility in the U.S. and manufacturing capacity in China through Jazz's partnerships with ASMC and HHNEC.

On January 7, Tower Semiconductor Ltd. announced a $20 million cash investment in the Company by Israel Corp. This is pursuant to the agreement between the parties announced on September 25, 2008. Israel Corp. invested $20 million for Tower's equity equivalent capital notes based on a $0.26 value per share. The equity equivalent capital notes have no voting rights, no dividend rights, are not tradable, do not carry interest, have no linking to any index and are not redeemable.

Russell Ellwanger, Chief Executive Officer of Tower, commented, "We are pleased that Israel Corp. continues to show its support of Tower. This additional capital will assist us in continuing our efforts to become the leading specialty foundry in the world and will provide needed flexibility as we continue to leverage the synergies inherent in our merger with Jazz Technologies and streamline our world-wide operations."

Tower Semiconductor Ltd. (TSEM) closed today's trading at $0.18 up $0.02 or 10.09 percent. Volume was 135,900 for a 3-month average volume of 243,398.

MIV Therapeutics Inc. (MIVI)

SmallCap Voice reported earlier on MIV Therapeutics Inc. (MIVI), Knobias did previously, and we are highlighting the Company here at the QualityStocks Daily Newsletter.

MIV Therapeutics is developing a line of advanced biocompatible coatings for passive and drug-eluting applications on cardiovascular stents, as well as for other implantable medical devices. The Company has their corporate headquarters in Vancouver , British Columbia . Trading on the OTCBB, they are involved in a collaborative research agreement with the University of British Columbia and received a government grant for their research program on the "Development of Novel Drug Eluting Composite Coatings for Cardiovascular Stents." This is under the National Research Council-Industrial Research Assistance Program.

The Company announced on March 31, 2008 the nine-month results from the first-in-man (FIM) MIVT Pilot Trial of their VESTAsync™ drug-eluting stent. This is their polymer-free drug-eluting stent. The results suggest the stent has the potential for superior safety and equivalent effectiveness. This is when compared to currently available drug-eluting stents. In August 2008, MIV reported continued excellent results of VESTAsync™, at a twelve-month clinical follow up for all fifteen patients in their first-in- man (FIM) VESTASYNC I Trial.

MIV Therapeutics Inc. designed their ultra-thin coating to protect surrounding tissue from potentially harmful interactions with bare metallic stents. This coating platform comes from hydroxyapatite (HAp), an organic material with demonstrated in vivo safety and biocompatibility. Hydroxyapatite is a porous material that makes up the bone mineral and matrix of teeth. It finds use as a bone substitute material and for coatings on implantable fixation devices in orthopedic, dental, and other applications.

The Company also designs their drug-eluting coatings to suit a wide variety of implantable medical devices that could benefit from customizable drug release profiles. MIV's intellectual property portfolio includes patents held by the University of British Columbia and exclusively licensed to MIV. The Company files key patent applications simultaneously in several countries to protect the commercial exclusivity of their inventions in the global marketplace.

The Journal of the American College of Cardiology Intervention (JACC Intervention) published preliminary results from the VESTASYNC I trial. The peer-reviewed article titled, "Preliminary Results of the Hydroxyapatite Non-Polymer-Based Sirolimus-Eluting Stent for the Treatment of Single De Novo Coronary Lesions - A First-In-Human Analysis of a Third Generation Drug-Eluting Stent (DES) System" appeared in the October 21, 2008 edition of JACC and is available online at http://interventions.onlinejacc.org/.

Along with the VESTASYNC I trial, MIV Therapeutics continues to enroll patients in the VESTASYNC II trial. The VESTASYNC II trial is a 120 patient randomized controlled study to demonstrate the safety and efficacy of the VESTAsync™ Stent in a larger group of patients. The Company anticipates that the VESTASYNC II results will form the basis of a regulatory filing for marketing approval in Europe .

MIV Therapeutics Inc. (MIVI) closed today's session at $0.35 up $0.09 or 34.62 percent. Volume was 2,610 for a 3-month average volume of 22,575.

OpenCell BioMed Inc. (OCBM)

Today, OTC Stock Exchange reported on OpenCell BioMed Inc. (OCBM) and we highlight the Company as well here at the QualityStocks Daily Newsletter.

OpenCell BioMed Inc. is a medical device designer and manufacturer. They specialize in innovative designs merging proprietary biomedical materials with human cell biology. Headquartered in Toronto , Ontario , they are developing a unique line of dental implants and related products for sale worldwide. Trading on the OTCBB, their corporate mission is to advance biomedical materials in the medical device industry with worldwide distribution of innovative products, scientifically designed to optimize the quality of patient care.

OpenCell Biomed has their proprietary paradigm shift surface coating/material TI-FOAM™. The use for this product is as a bone to implant interface. It enables dental implant systems greater short and long-term stability. It accomplishes this with minimally invasive techniques compared to traditional dental implant systems. The Company's Proprietary Porous Titanium Foam (TI-FOAM™) Coated Dental Implants come in threaded and full foam designs, have component abutments, and come in sterile packaging.

OpenCell BioMed Inc.'s founder and CEO is Mislav Pavelic, Doctor of Dental Surgery, Fellow International Congress of Oral Implantology. Dr. Pavelic has owned, operated, and developed many multi-disciplined healthcare clinics in the Greater Toronto Area (GTA) over the past 20 years. He has developed specialized post-graduate clinical training systems for dentists in high demand, high-end dental implant, and laser procedures. He has also developed "Servadent" a portal web-based multi-disciplined management program to control and manage these clinical training systems.

Dr. Pavelic believes that OpenCell BioMed Inc. and their proprietary products are in a position that will bring the Company years of growth. This is due to the aging population and the doubling in the last decade of healthcare spending. Studies show 69 percent of adults' ages 35 to 44 have lost at least one permanent tooth to an accident, gum disease, a failed root canal, or tooth decay. By age 74, 26 percent of adults have lost all of their permanent teeth and the number of Americans over 55 will continue to grow by 60 percent in the next 20 years.

OpenCell BioMed Inc. (OCBM) closed today's session at $0.40 down $0.05 or 11.11 percent. Volume was 35,534 shares for a 3-month average volume of 15,991.10 shares.

Curis Inc. (CRIS)

Stock Stars.net reported yesterday on Curis Inc. (CRIS), Knobias did previously, and we are highlighting the Company here at the QualityStocks Daily Newsletter.

Curis Inc. is a drug development company committed to leveraging their innovative signaling pathway drug technologies to create new medicines for cancer. Headquartered in Cambridge , Massachusetts , the Company is expanding their drug development efforts in the field of cancer through their targeted cancer drug development platform. The Company trades on the NASDAQ Global Market. Founded in 2000, Curis Inc. has approximately forty employees.

They are also using their signaling pathway-based preclinical drug development experience to develop drug candidates that target additional signaling pathways. Their Targeted Cancer Drug Development Platform consists of several proprietary cancer drug programs. These programs target multiple signaling pathways other than the Hedgehog pathway. Their programs focus on developing a number of proprietary small molecule inhibitor drug compounds, including CUDC-101. They design each compound to inhibit one or more clinically validated cancer targets that include both kinases and non-kinases.

In December, Curis announced that their collaborator Genentech initiated a Phase II clinical trial of GDC-0449. This is an orally administered small molecule Hedgehog pathway inhibitor. The trial is to determine GDC-0449 as a maintenance therapy for ovarian cancer patients in second or third complete remission. Under the collaboration agreement, Curis will receive a $3 million cash payment from Genentech.

Yesterday, the Company announced that Genentech indicated that it expects to initiate this month a pivotal Phase II clinical trial of GDC-0449 as a single-agent therapy for patients with metastatic or locally advanced basal cell carcinoma. Under the collaboration agreement, Curis will receive a $6 million cash payment from Genentech following initiation of the trial.

"In addition to the near-term advancement of this promising clinical candidate, this pivotal trial initiation has added significance because it provides Curis with $6 million in non-dilutive cash that, when added to our existing capital, is sufficient to fund our currently-planned operations into mid-2010," said Curis Inc. Chief Operating and Chief Financial Officer Mike Gray.

Curis Inc. (CRIS) closed today's session at $0.90 up $0.07 or 8.47 percent. Volume was 81,770 for a 3-month average volume of 106,878.

Interoil Corp. (IOC)

Today, Greenbackers reported on Interoil Corp. (IOC), Undiscovered Equities did previously, and we choose to highlight the Company here at the QualityStocks Daily Newsletter.

InterOil Corporation is developing a vertically integrated energy business. Their focus is Papua New Guinea and the surrounding region. The Company has offices in Cairns , Australia , The Woodlands, Texas , and Port Moresby , Papua New Guinea .

InterOil's assets are petroleum licenses covering approximately 8.7 million acres, an oil refinery, and retail and commercial distribution facilities. These assets are all in Papua New Guinea . They are also a shareholder in a joint venture established to construct Papua New Guinea 's first liquid natural gas plant. This is on a site next to their refinery in Port Moresby . The joint venture company is targeting 2012 for the delivery of 'first gas'.

The Company currently has four exploration licenses and two retention licenses in Papua New Guinea . InterOil Corp. constructed and has ownership of a 32,500 bpd nameplate-design Commercial Oil Refinery. It has a proven throughput of 36,500 bbls per day. The refinery is the only one in Papua New Guinea , supplying the country's refined product needs. The Company has a crude oil supply contract with BP Singapore and refined product sales contracts with Royal Dutch Shell.

In addition, InterOil is the largest distributor of refined products in Papua New Guinea . They distribute under their branded name InterOil Products Limited. This business grew through the acquisition of distribution assets previously owned and operated by BP and Shell in the country. InterOil Products Limited owns and operates distribution depots, seaboard terminals, trucking systems, and a retail network.

On Wednesday, InterOil Corporation announced the appointment of Mr. Wayne Andrews as Vice President of Capital Markets. He joins the Company from Raymond James and Associates Inc. There, he was Managing Director of Exploration & Production Equity Research. Focusing on the oil and natural gas industry, Mr. Andrews joined Raymond James in 1996 after spending three years as natural gas analyst at Schroder Wertheim. Mr. Andrews holds a Bachelor of Arts degree in geology from Franklin & Marshall College , a Master of Science degree in geology from the University of Delaware , and a M.B.A. from Southern Methodist University.

Interoil Corp. (IOC) closed today's trading at $20.30 up $0.50 or 2.53 percent. Volume was 443,652 for a 3-month average volume of 410,358.

NACEL Energy Corp. (NCEN)

Today, OTC Stock Exchange and HotOTC.com reported on NACEL Energy Corp. (NCEN), and we highlight the Company here at the QualityStocks Daily Newsletter.

NACEL Energy is engaged in generating clean, renewable energy from wind. Their focus is on the development of utility-class wind-power generation projects located in Texas , other domestic locations, and in the Dominican Republic . Founded in 2006 as Zephyr Energy Corporation, the Company changed their name to NACEL Energy Corporation in 2007.

Headquartered in Cody , Wyoming , the Company trades on the OTCBB, and is one of the first publicly traded companies in America exclusively developing utility class wind power generation facilities. These are utility-scale wind energy projects using state-of-the-art turbines with a sustainable footprint of 20 to 30 MW and local investor-partners. There can be a competitive advantage possible with this form over other forms of wind energy development. This is due to faster permitting times, local political support, and additional government incentives.

NACEL Energy collaborates with local wind developers. They offer solutions to the absence of a tax-efficient structure to utilize Federal and/or State incentives for wind energy development, and the scarcity of capital for early-stage projects. They do this through WINDVEST™. This is their proprietary capital structure and process, which enables them to joint venture with local wind energy developers, speed up timelines, and improve project economics.

After they successfully complete feasibility and financial reviews, NACEL Energy establishes their WINDVEST™ financial partnership structure. This creates the ownership positions in the project and facilitates the raising of capital. At the end of the WindVest™ process, a long-term wind development rights agreement to the landowner is provided. This agreement offers royalty and other monetary payments.

Interest in community wind energy development is growing in America . Projects can be single turbines erected by municipal utilities, school districts, and tribal reservations, to larger multi-turbine installations. The Company is currently developing their Blue Creek and Channing Flats, Texas projects. The total planned generating capacity of NACEL Energy's new wind domestic energy projects is 50 MW. This is more than the normal footprint, and enough energy to power 25,000 American homes. NACEL Energy is also pursuing development of a three-phase wind energy project in the Dominican Republic . There hope is that this project will supply 600MW of clean, renewable, wind power to this region that relies heavily on fossil fuels.

Last week, NACEL Energy Corporation confirmed that they commenced the collection of site-specific wind measurement data at their Channing Flats project site in Moore County , Texas . This is with the installation of a 60 meter (200 ft.) NRG Systems meteorological tower transmitting data back to NACEL Energy, via an Iridium satellite uplink. NACEL Energy's analysis indicates that the construction of a series of 10 MW phases is optimal at Channing Flats. Their analysis also indicates that 20 MW, or more, of generating capacity may be achievable.

Nacel Energy Corp. (NCEN) closed Friday's trading at $2.05 up $0.55 or 36.67 percent. Volume was 322,432 for a 3-month average volume of 40,801.60.

Sunrise Solar Corporation (SSLR)

Today, OTC Stock Exchange reported on Sunrise Solar Corporation (SSLR), Standout Stocks, HotOTC.com, StockEgg.com did this week, and we choose to highlight the Company here at the QualityStocks Daily Newsletter.

Headquartered in San Antonio , Texas , Sunrise Solar Corporation intends to commercialize and distribute innovative alternative solar energy technologies and equipment. An OTCBB traded corporation, Sunrise also intends to capitalize on their institutional knowledge of emerging alternative energy technologies. This is so they can develop comprehensive alternative energy plans.

Sunrise Solar Corporation's main service is their expert consultancy for advising organizations on how to secure alternative energy contracts with public utilities. They use their understanding of solar technology to support the development of alternative energy plans for enterprise clientele.

Sunrise Solar has agreed to sell a newly developed solar lighting system. This is the Solar Brick. This technology includes advanced solar cells, an energy storage device, and a crystal lighting system that surrounds the energy module in a square or rectangle. The imbedded solar cell generates electricity from the sun and stores it in the storage device. When it is dark, automatic activation of the lights occurs. The design of the solar brick is so that it lights in any color. Potential applications for this solar brick include rural airfields, building lighting, safety lights, and decorative lighting. One can operate the solar brick without any connection to the electrical grid. It is also embeddable into construction materials.

The Company's product portfolio also includes a solar sunroof. This replaces the typical glass sunroof with advanced solar technology. The solar sunroof can cool a car when it is off or parked. It can also heat a parked car in colder climates. In addition, it is capable of generating electricity to help recharge a car's electrical system.

Sunrise Solar's Solar Phone Charger offering includes a solar cell and a USB storage device in one. It can charge the battery on a laptop or cell phone. The Company will also sell their Solar Cells products. These are for capturing the suns energy, converting it into electricity and storing it in electrical storage devices. Their Solar lighting systems include the solar cell, storage device, and lighting systems for applications disconnected from the power grid.

On Wednesday, Sunrise Solar Corp. announced that their management team would visit Brazil next week. This is for site visits to projects announced in Brazil . They are also expecting to meet with South American funding partners. The management team will make on site assessments and work to finalize major projects in Brazil .

Eddie Austin, Chairman and CEO of Sunrise Solar Corp. said, " Brazil is one of the most energy independent countries in the world. We are excited about the willingness of institutions in Brazil to increase their energy efficiency through the installation of solar power. We plan to expand our presence in Brazil due to its role as a world leader in alternative energy."

Sunrise Solar Corporation (SSLR) closed today's session at $0.80 up $0.10 or 14.29 percent. Volume was 354,411 for a 3-month average volume of 143,097.

The QualityStocks Company Corner

Hunt Gold Corp. (HGLC)
Kraig Biocraft Laboratory (KBLB)

QuoteMedia, Inc. (QMCI)
Nexia Holdings, Inc. (NXHD)

Hunt Gold Corp. (HGLC)

The QualityStocks Daily Newsletter would like to spotlight Hunt Gold Corp. (HGLC) Today, Hunt Gold Corporation closed trading at $0.0001, for no change from yesterday's close. Their volume today was 177,254,942 shares significantly higher than their 3-month average volume of 1,435,980 shares.

Hunt Gold Corporation (HGLC) confirms that they are disposing of their "Lookout Silver" Mine. The Company is in the process of staking additional claims surrounding this mine and is disposing of the "entire package."

Hunt Gold Corporation (HGLC) is a gold mining and exploration company focused on the development and exploration of their “Mockingbird,” “Ambassador,” “Golden Eagle,” “Gladstone Lookout,” “Lady Alde,” “Lookout Silver,” “Starlight,” “American Flag,” “Venezia,” “Stormcloud,” “Cherry,” “Buffalo Limecap,” “Red Cloud” and “Federal” gold properties.

The company is currently in the process of drilling on its “Mockingbird” Gold Property. The property consists of approximately 2,500 acres and is located in Mohave County, Arizona. Previous mining efforts identified the property as having the potential to hold more than a million ounces of gold resource. Hunt Gold's drilling program was initiated to verify the gold mineralization previously identified by surface sampling, and to begin building a proven or probable gold resource.

The Ambassador Gold Project is located near Prescott, Arizona in the Black Hills Mining District, which is south of the Verde Mining District and west of the Cherry Creek Mining District. Each of these districts has seen significant past production of gold, silver and copper. Well-known area mines include the United Verde, United Verde Extension, Yaeger, Monarch and Logan Mines.

The Golden Eagle property is geographically located between and on trend with the Mesquite gold mine and the Picacho gold mine. Mesquite was mined by Newmont for over 15 years and produced a total of 4MM ounces gold, while Picacho produced 388,000 ounces of gold. Past exploration by UNC focused on sampling of the underground workings of the Ambassador Mine, which showed excellent gold grades at the mine exposures and the potential for developing an economic ore deposit of over 1,000,000 ounces of gold and gold equivalent silver and copper credits. Disclaimer

Hunt Gold Corp. Daily Blog

Hunt Gold Corp. News:

Hunt Gold Corporation -- Sale of "Lookout Silver Mine"

Hunt Gold Corporation -- Company Acquires Additional Mines & Stakes 26 Lode Mining Claims

Hunt Gold Corporation - Completion of January Drilling Campaign

Kraig Biocraft Laboratories, Inc. (KBLB)

The QualityStocks Daily Newsletter would like to spotlight Kraig Biocraft Laboratories, Inc. (KBLB). Today, Kraig Biocraft Laboratories, Inc. closed trading at $0.24, which was up $0.04 or 20.00 percent from yesterday's close. Their volume today was 17,600 shares for a 3-month average volume of 3,175 shares.

Kraig Biocraft Laboratories, Inc. (KBLB) a biotechnology company, has their focus on developing high performance polymers and technical fibers. The company is utilizing their proprietary genetic engineering technology to develop and produce polymers and protein-based materials, including Spider silk, which may have numerous commercial and consumer applications.

Kraig Biocraft Laboratories, Inc. is working with university scientists and laboratories to create these new polymers that have potentially broad applications in the multi-billion dollar marketplace for high performance polymers. The company sponsors and collaborates on research projects within university genetic engineering laboratories as a means of utilizing the greatest minds in their field.

Spider Silk is one of the strongest fibers produced in nature. The spider's repelling silk is of particular commercial interest since it is both extremely strong and extremely flexible. Although exciting commercial opportunities exist for the natural polymer, there is no known way to produce the fibers in commercial quantity. KraigLabs, in cooperation with two leading universities, has acquired proprietary genetic engineering technology to unlock the mystery.

CEO Kim Thompson leads the company with formal education in the fields of economics and law. With interest in genetic engineering dating back to the 1970s, Mr. Thompson has invented a pending provisional patent application for a number of organic polymers. This patent application has been assigned to benefit Kraig Biocraft and is a central part of the company's efforts in bringing those inventions to the market. Disclaimer

Kraig Biocraft Laboratories, Inc. Daily Blog

Kraig Biocraft Laboratories, Inc. News:

Kraig Biocraft Laboratories, Inc. Announces a Large Increase in Laboratory Productivity Including a Doubling of Gene Transfers Performed

Kraig Biocraft Laboratories, Inc. Announces Research Team Member Completes Successful Trip to Overseas Laboratory to Boost Spider Silk Polymer Development

Kraig Biocraft Laboratories, Inc. Announces Acceleration of Polymer Research and Development With Another Significant Addition to Research Team

QuoteMedia, Inc. (QMCI)

The QualityStocks Daily Newsletter would like to spotlight QuoteMedia Inc. (QMCI). Today, QuoteMedia Inc. Inc. closed trading at $0.07, which was up $0.01 or 7.69 percent. Their volume today was 16,100 shares. Their 3-month average volume is 22,273.40 shares.

QuoteMedia, Inc. (QMCI) is a leading data provider of financial stock market data , market news feeds, and related financial software solutions to financial service companies, online brokerages, clearing firms, banks and public corporations.

The Company's diversity of technical expertise, its agile responsiveness to custom corporate requirements, and its proven commitment to superior delivery technologies have established QuoteMedia as a frontrunner in the financial market data industry.

QuoteMedia, Inc's low cost data provision contracts, combined with other factors such as the Company's uniquely streamlined, cost-effective and proprietary data delivery systems, provide healthy margins even at the wholesale level. Most of QuoteMedia's competitors use outdated data delivery technologies based on legacy style data networks that incur more bandwidth, heavier server and network loads, higher server costs, and higher data delivery costs. Disclaimer

QuoteMedia, Inc. Daily Blog

QuoteMedia, Inc. News:

QuoteMedia Reports 26% Increase in Revenue for Q3 2008; and 33% Increase for Comparative 9 Month Period

QuoteMedia Reports 30% Increase in Revenue for Q2 2008

QuoteMedia Announces Enterprise Agreement with Penson Worldwide

Nexia Holdings, Inc. (NXHD)

The QualityStocks Daily Newsletter would like to spotlight Nexia Holdings, Inc. (NXHD) Today, Nexia Holdings, Inc. closed trading at $0.0002, for no change. Their volume today was 188,360,660 shares.

Nexia Holdings, Inc. is a diversified holdings company with operations in health and beauty, fashion retail, and real estate. Currently, the company owns two salons, one retail store, one online retail store and three commercial properties.

The two salons, Landis Lifestyle Salon and Landis Salon, are both located in Utah. Landis Lifestyle Salon, located in Salt Lake City, is an Aveda™ Lifestyle Salon, while Landis Salon, located in Bountiful, is an Aveda™ Concept Salon. Nexia plans to grow the Landis brand to a national level with up to 5 locations in the Salt Lake region before executing a national expansion plan that could include franchise opportunities.

The retail store, operated by subsidiary Black Chandelier, sets itself apart from clothing giants such as The Gap, Hot Topic, and Target by offering eco-friendly fabrics, in-house sewers and silk screeners, and crazy models like Lisa D'Amato. The store was designed to be a tourist attraction that offers an innovative retail shopping experience.

Nexia Holdings, Inc. also has more than a decade of experience acquiring undervalued properties in the area of Salt Lake City. The company's existing portfolio includes the historic Wallace-Bennett Building (a 38,000 sq. ft. multi-story office building in Salt Lake City), a 7,000 sq. ft. one-story retail building on State Street in Salt Lake City, and 100,000 sq. ft. building on Sam's Boulevard in Kearns. The company also owns seven small parcels of undeveloped raw land in Utah and Kansas. Disclaimer

Nexia Holdings, Inc. Blog

Nexia Holdings, Inc. News:

Nexia CEO Richard Surber Shares His Insights With Shareholders

Nexia Set to Acquire Seven Residential Properties in Northern Utah

Nexia Reports Salon Revenues of $2,113,943


Daily Video
Get the latest market news every weekday at 11am EST with QualityStocks.net anchors Cathy Rankin, Vanessa Ramirez and Jenn Hoffman.

Sponsors of the Day

The QualityStocks Public Company Sponsor News


QualityStocks By The Numbers Report




About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks.net 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-308-0703